Concepedia

Author

Davide Soldato

Institut Gustave RoussyORCID

Also Known As

D. Soldato, Davide Soldato

74

Publications

885

Citations

17

H-Index

6

Concepts

All Affiliations

Institut Gustave RoussyInsermOspedale Policlinico San MartinoUniversity of GenoaUniCancer Group
DS

About

Davide Soldato is an author at Institut Gustave Roussy specializing in cancer therapeutics, lung cancer, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

22

2

Pathology

1

1

22

3

Cancer Therapeutics

1

1

22

4

Lung Cancer

1

1

22

5

Oncology

1

1

22

Davide Soldato

×

13

Publications

455

Citations

12

H-Index

YearCitations

Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)

Alberto Puccini, Kelsey Poorman, Mohamed E. Salem,

Clinical Cancer Research

2020

101

Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care

Antonio Di Meglio, Julie Havas, Davide Soldato,

Journal of Clinical Oncology

2022

56

Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis

Inês Vaz-Luís, Antonio Di Meglio, Julie Havas,

Journal of Clinical Oncology

2022

52

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

Vera Hirsh, Sandro Pignata, Melissa Bersanelli,

Journal of Translational Medicine

2017

43

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

Alessio Cortellini, Biagio Ricciuti, Victor R. Vaz,

Journal for ImmunoTherapy of Cancer

2022

35

Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak

Marco Tagliamento, Francesco Spagnolo, Francesca Poggio,

European Journal of Clinical Investigation

2020

34

Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes

Maria Alice Franzoi, M. Aupomerol, Julie Havas,

ESMO Open

2024

29

Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer

Carlo Cattrini, Davide Soldato, A. Rubagotti,

Cancers

2020

22

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

Édouard Auclin, José Carlos Benítez, Marco Tagliamento,

Lung Cancer

2023

22

Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients

Alberto Puccini, Andreas Seeber, Joanne Xiu,

npj Precision Oncology

2021

19

Page 1